{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05856227",
            "orgStudyIdInfo": {
                "id": "BPR-PIP-003"
            },
            "organization": {
                "fullName": "Basilea Pharmaceutica",
                "class": "INDUSTRY"
            },
            "briefTitle": "Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age",
            "officialTitle": "A Multicenter, Open-label, Single-arm, Multiple-dose Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Ceftobiprole Medocaril in Term and Pre-term Neonates and Infants up to 3 Months of Age With Late-onset Sepsis",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "late-onset-sepsis-in-term-and-pre-term-neonates-and-infants-up-to-months-of-age"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-17",
            "studyFirstSubmitQcDate": "2023-05-03",
            "studyFirstPostDateStruct": {
                "date": "2023-05-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Basilea Pharmaceutica",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will evaluate the safety, pharmacokinetics and efficacy of ceftobiprole in term and pre-term newborn babies and infants up to 3 months of age with late-onset sepsis (LOS). Ceftobiprole is an antibiotic which belongs to a group of medicines called 'cephalosporin antibiotics'. It is approved for its use to treat adults and children with pneumonia in many European and non-European countries.",
            "detailedDescription": "This is a multicenter, open-label, single-arm, multiple-dose study of intravenous (IV) ceftobiprole medocaril (prodrug of the active moiety ceftobiprole). It may be combined with ampicillin and/or an aminoglycoside based on the Investigator's judgement according to manufacturer's instructions and/or local standard of care.\n\nFollowing screening, ceftobiprole will be administered as a 2-hour infusion at a dose of 7.5 mg/kg every 12 hours to 15 mg/kg every 8 hours, depending on age and weight.\n\nThe target treatment duration is 7-10 days, which may be either extended to 14 days if considered clinically necessary by the Investigator or may be may be stopped after 5 days at the discretion of the Investigator based on resolution of signs and symptoms of sepsis and blood inflammation markers, in accordance with local standard of care."
        },
        "conditionsModule": {
            "conditions": [
                "Neonatal Sepsis"
            ],
            "keywords": [
                "Late-onset sepsis",
                "Neonates",
                "Infants"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment Arm: Ceftobiprole",
                    "type": "EXPERIMENTAL",
                    "description": "Ceftobiprole medocaril: 7.5 mg/kg to 15 mg/kg",
                    "interventionNames": [
                        "Drug: Ceftobiprole medocaril"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ceftobiprole medocaril",
                    "description": "Ceftobiprole medocaril: 7.5 mg/kg every 12 hours to 15 mg/kg every 8 hours, administered IV as a 2-hour infusion.",
                    "armGroupLabels": [
                        "Treatment Arm: Ceftobiprole"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety and tolerability by incidence of adverse events (AEs) and serious adverse events (SAEs)",
                    "description": "Descriptive statistics of AEs, SAEs, deaths, and discontinuations due to AEs during treatment with ceftobiprole",
                    "timeFrame": "Up to 5-7 weeks"
                },
                {
                    "measure": "Number of participants with clinically relevant findings in laboratory tests",
                    "description": "Descriptive statistics of clinical laboratory tests (including hematology, blood chemistry, urinalysis) and the change from baseline to each post-baseline visit value will also be summarized",
                    "timeFrame": "Up to 5-7 weeks"
                },
                {
                    "measure": "Number of participants with clinically relevant findings in vital signs",
                    "description": "Descriptive statistics of vital signs findings including body temperature, respiratory rate, pulse rate, and systolic and diastolic blood pressures",
                    "timeFrame": "Up to 5-7 weeks"
                },
                {
                    "measure": "Number of participants with clinically relevant findings in physical examination",
                    "description": "Descriptive statistics of physical examination findings including examination of general appearance, skin, head, neck, eyes, ears, nose, throat, cardiovascular system, thorax/lungs, abdomen, lymph nodes, extremities, and nervous system",
                    "timeFrame": "Up to 5-7 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Observed plasma concentrations of ceftobiprole, ceftobiprole medocaril, and open-ring metabolite",
                    "description": "Descriptive analyses of these concentrations will be summarised by timepoint for term and pre-term neonates with post-natal age up to 3 months.",
                    "timeFrame": "At day 3"
                },
                {
                    "measure": "Clinical response",
                    "description": "Clinical cure rate at the end of treatment (EOT) at day 7-14 and test of cure (TOC) at 7-14 days after last ceftobiprole dose visits in the Intent-to-Treat (ITT) and Clinically Evaluable (CE) populations",
                    "timeFrame": "5-7 weeks"
                },
                {
                    "measure": "All-cause mortality",
                    "description": "All-cause mortality (ITT population)",
                    "timeFrame": "through Day 28"
                },
                {
                    "measure": "Microbiological response",
                    "description": "Microbiological eradication or presumed eradication rate at the EOT and TOC visits (in the Microbiological Intent-to-Treat \\[mITT\\] and Microbiologically Evaluable \\[ME\\] populations)",
                    "timeFrame": "5-7 weeks"
                },
                {
                    "measure": "Number of participants with improved signs and symptoms of LOS",
                    "description": "Improved signs and symptoms of LOS (including fever, hypothermia, abnormal heart rate, signs of impaired circulation, petechial rash or sclerema neonatorum, respiratory distress, gastrointestinal distress, irritability, lethargy and/or muscular or arterial hypotonia) will be assessed at Day 3, EOT, and TOC visits (ITT and CE populations)",
                    "timeFrame": "At the Day 3 and up to 5-7 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Informed consent from parent(s) or other legally acceptable representative (LAR) to participate in the study\n* Male or female, with a gestational age of \u2265 24 weeks and a post-natal age ranging from \u2265 3 days to \u2264 3 months\n* Diagnosis of documented or presumed bacterial LOS requiring administration of systemic antibiotic treatment\n* Sufficient vascular access to receive study drug and to allow blood sampling at a site separate from the study drug infusion line\n\nKey Exclusion Criteria:\n\n* Refractory septic shock not responding to 60 minutes of vasopressor treatment within 48 hours before enrollment\n* Proven ventilator-associated pneumonia\n* Proven central nervous system infection (e.g., meningitis, brain abscess)\n* Proven osteomyelitis, infective endocarditis, or necrotising enterocolitis\n* Impaired renal function or known significant renal disease, as evidenced by an estimated glomerular filtration rate (using the Schwartz formula or other applicable formula) calculated to be less than 2/3 of normal for the applicable age group, OR urinary output \\< 0.5 mL/kg/h (measured over at least 8 hours), OR requirement for dialysis\n* Progressively fatal underlying disease, or life expectancy \\< 30 days\n* Use of systemic antibacterial therapy for longer than 48 hours within 7 days before start of study medication\n* Participation in another clinical study with an investigational product within 30 days of enrollment in the current study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "genderBased": true,
            "genderDescription": "Male or female",
            "minimumAge": "3 Days",
            "maximumAge": "3 Months",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marc Engelhardt, MD",
                    "role": "CONTACT",
                    "phone": "+41 79 701 0551",
                    "email": "marc.engelhardt@basilea.com"
                },
                {
                    "name": "Manuel H\u00e4ckl, MD",
                    "role": "CONTACT",
                    "phone": "+41 615671533",
                    "email": "manuel.haeckl@basilea.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marc Engelhardt, MD",
                    "affiliation": "Basilea Pharmaceutica International Ltd, Allschwil",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "NorthShore University HealthSystem-Evanston Hospital",
                    "status": "RECRUITING",
                    "city": "Evanston",
                    "state": "Illinois",
                    "zip": "60201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.04114,
                        "lon": -87.69006
                    }
                },
                {
                    "facility": "West Virginia University",
                    "status": "RECRUITING",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26506",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                },
                {
                    "facility": "MHAT Dr. Stamen Iliev AD Montana, Neonatology Department",
                    "status": "RECRUITING",
                    "city": "Montana",
                    "zip": "3400",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 43.4125,
                        "lon": 23.225
                    }
                },
                {
                    "facility": "UMHAT \"Sveti Georgi\" EAD, Pediatric surgery Clinic",
                    "status": "RECRUITING",
                    "city": "Plovdiv",
                    "zip": "4000",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 42.15,
                        "lon": 24.75
                    }
                },
                {
                    "facility": "\"Acibadem City Clinic University Hospital Tokuda\" EAD, Neonatology Department",
                    "status": "RECRUITING",
                    "city": "Sofia",
                    "zip": "1407",
                    "country": "Bulgaria",
                    "geoPoint": {
                        "lat": 42.69751,
                        "lon": 23.32415
                    }
                },
                {
                    "facility": "Tallinn Childrens' Hospital",
                    "status": "RECRUITING",
                    "city": "Tallinn",
                    "zip": "13419",
                    "country": "Estonia",
                    "geoPoint": {
                        "lat": 59.43696,
                        "lon": 24.75353
                    }
                },
                {
                    "facility": "Klinikum der Universit\u00e4t M\u00fcnchen, Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital",
                    "status": "RECRUITING",
                    "city": "Munich",
                    "state": "Bavaria",
                    "zip": "80337",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.13743,
                        "lon": 11.57549
                    }
                },
                {
                    "facility": "Pauls Stradins Clinical University Hospital",
                    "status": "RECRUITING",
                    "city": "Riga",
                    "zip": "1002",
                    "country": "Latvia",
                    "geoPoint": {
                        "lat": 56.946,
                        "lon": 24.10589
                    }
                },
                {
                    "facility": "Children Clinical University Hospital - Neonatology Clinic",
                    "status": "RECRUITING",
                    "city": "Riga",
                    "zip": "1004",
                    "country": "Latvia",
                    "geoPoint": {
                        "lat": 56.946,
                        "lon": 24.10589
                    }
                },
                {
                    "facility": "Lithuanian Health Science University Hospital Kauno klinikos - Neonatology Clinic",
                    "status": "RECRUITING",
                    "city": "Kaunas",
                    "zip": "50161",
                    "country": "Lithuania",
                    "geoPoint": {
                        "lat": 54.90272,
                        "lon": 23.90961
                    }
                },
                {
                    "facility": "Vilnius University Hospital Santaros klinikos - Neonatology Center",
                    "status": "RECRUITING",
                    "city": "Vilnius",
                    "zip": "08410",
                    "country": "Lithuania",
                    "geoPoint": {
                        "lat": 54.68916,
                        "lon": 25.2798
                    }
                },
                {
                    "facility": "Ginekologiczno-Po\u0142o\u017cniczy Szpital Kliniczny im. Marcinkowskiego",
                    "status": "RECRUITING",
                    "city": "Poznan",
                    "zip": "60-535",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.40692,
                        "lon": 16.92993
                    }
                },
                {
                    "facility": "Szpital Uniwersytecki - Klinika Neonatologii",
                    "status": "RECRUITING",
                    "city": "Wroclaw",
                    "zip": "50-556",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.1,
                        "lon": 17.03333
                    }
                },
                {
                    "facility": "Univerzitna nemocnica Martin",
                    "status": "RECRUITING",
                    "city": "Martin",
                    "zip": "03659",
                    "country": "Slovakia",
                    "geoPoint": {
                        "lat": 49.06651,
                        "lon": 18.92399
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000018805",
                    "term": "Sepsis"
                },
                {
                    "id": "D000014115",
                    "term": "Toxemia"
                },
                {
                    "id": "D000071074",
                    "term": "Neonatal Sepsis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000018746",
                    "term": "Systemic Inflammatory Response Syndrome"
                },
                {
                    "id": "D000007249",
                    "term": "Inflammation"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M20864",
                    "name": "Sepsis",
                    "asFound": "Sepsis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25869",
                    "name": "Premature Birth",
                    "relevance": "LOW"
                },
                {
                    "id": "M16869",
                    "name": "Toxemia",
                    "asFound": "Sepsis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M696",
                    "name": "Neonatal Sepsis",
                    "asFound": "Neonatal Sepsis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M20818",
                    "name": "Systemic Inflammatory Response Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000443755",
                    "term": "Ceftobiprole"
                },
                {
                    "id": "C000505439",
                    "term": "Ceftobiprole medocaril"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M351854",
                    "name": "Ceftobiprole",
                    "asFound": "TEG",
                    "relevance": "HIGH"
                },
                {
                    "id": "M99697",
                    "name": "Ceftobiprole medocaril",
                    "asFound": "Sentinel Lymph Node Mapping",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}